Speaker Profile
M.D., Director of Molecular Pathology Services, NeoGenomics Laboratories
Biography
Dr. Shari Brown joined NeoGenomics as a Molecular Pathologist in 2018. Dr. Brown previously served as Director of Molecular Pathology and Informatics and Interim Director of Histology and Gross Pathology in addition to her role as Surgical Pathologist for Memphis Pathology Group. Dr. Brown was a Clinical Instructor/Advanced Surgical Pathology Fellow at East Carolina University, Brody School of Medicine and completed her fellowship in Molecular & Genetic Pathology at Oregon Health & Science University, and her residency at University of Hawaii. Dr. Brown’s publications include a chapter on the molecular pathology of solid tumors in Cheng and Bostwick’s Essentials of Anatomic Pathology. Dr. Brown’s areas of interest and investigation include structured educational training modules for pathology education and training, error correction techniques for next-generation sequencing data, use of clinical bioinformatics tools for managing cancer patients, and somatic mutations related to disease progression in acute myeloid leukemia.
Session Abstract – PMWC 2020 Silicon Valley
Cancer genomic profiling can identify germline and medically actionable mutation(s) in cancer predisposition genes. This can present a complex problem for diagnostics labs because of broader implications regarding the patient’s overall health risk, risk of future cancers, and implications for the patient’s family. This panel discussion will focus on how diagnostics labs are addressing this complexity.
